Livagen dosage chart
20 mg Vial
Livagen is dosed at 500 mcg–2 mg daily via subcutaneous injection in educational protocols. A 20 mg vial reconstituted with bacteriostatic water yields about 6.67 mg/mL. This information is for research and educational use only.
- Reconstitute
- Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
- Typical daily range
- 0.5–2.0 mg once daily (gradual titration over 8–12 weeks).
- Easy measuring
- At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 0.0667 mg (66.7 mcg) on a U-100 insulin syringe.
- Storage
- Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
- Injection frequency
- Once daily — 5 days on, 2 days off (dose Mon–Fri, rest Sat–Sun).
- Dosing schedule
- 5 days on / 2 days off: dose Monday through Friday, then take Saturday and Sunday off. That is 5 dosing days per week.
Dosing schedule
| Week | Daily Dose (mg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 0.5 mg (500 mcg) | 7.5 units (0.075 mL) |
| Weeks 3–4 | 1.0 mg (1000 mcg) | 15 units (0.15 mL) |
| Weeks 5–6 | 1.5 mg (1500 mcg) | 22.5 units (0.225 mL) |
| Weeks 7–12 | 2.0 mg (2000 mcg) | 30 units (0.30 mL) |
Reconstitution steps
- 1Draw 3.0 mL bacteriostatic water with a sterile syringe.
- 2Inject slowly down the vial wall; avoid foaming.
- 3Gently swirl/roll until dissolved (do not shake).
- 4Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Dosing Cycle & Timing
This protocol runs on a 5 days on / 2 days off cycle.
- Cycle: 5 days on, 2 days off — dose Monday through Friday and rest on the weekend.
- 5 dosing days per week; the 2 off days help limit receptor desensitisation and give injection sites time to recover.
- Keep the dose time consistent on dosing days.
- If a weekday dose is missed, take it the same day if possible — do not dose on an off day to catch up.
- Weekly totals in the supplies and shopping lists are calculated on 5 dosing days, not 7.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes; dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- Inject slowly; wait a few seconds before withdrawing the needle.
- Document daily dose and site rotation to maintain consistency.
- No standardized human clinical administration studies exist for Livagen; dosing is extrapolated from preclinical data and similar peptide bioregulators.
How This Works
Livagen’s mechanisms involve peptidase inhibition and epigenetic modulation. The peptide strongly inhibits enkephalin-degrading enzymes (IC50 ≈ 20 μM) in human serum, which may prolong endogenous enkephalin activity. Notably, this occurs without direct opioid receptor binding. In aging cells, Livagen has been shown to induce heterochromatin decondensation and reactivate ribosomal genes. Preclinical studies in rat liver organ cultures demonstrated enhanced cellular structure and regenerative processes, while oral administration in aged rats shifted digestive enzyme activities toward youthful patterns.
Potential Benefits & Side Effects
Observations from preclinical and in vitro literature.
- Supports inhibition of enkephalin-degrading enzymes, potentially prolonging endogenous enkephalin signaling.
- May modulate gene expression and chromatin structure in aging tissues.
- Preclinical evidence suggests support for cellular homeostasis and regenerative capacity.
- In aged rodents, oral dosing normalized digestive enzyme activity toward youthful levels.
- No human clinical administration studies have been reported; side effect profile in humans is unknown.
- Occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.
Lifestyle Factors
Complementary strategies for best outcomes.
- Maintain a balanced, nutrient-dense diet to support cellular health.
- Engage in regular physical activity to reinforce metabolic and regenerative adaptations.
- Prioritize sleep quality and stress management to support overall homeostasis.
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
- Do not aspirate for subcutaneous injections; inject slowly and steadily.
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
- Dispose of used syringes immediately in a sharps container.
Important Note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.
Supplies needed
Plan covers the full 12-week protocol at the lowest listed starting dose: 0.5 mg per dose, 5 days on / 2 days off (60 administrations in total), using 20 mg vials. After mixing with 3 mL, the concentration is 6.67 mg/mL and each dose requires 0.08 mL total.
Livagen vials (20 mg each)
Vials are rounded up only after calculating the whole protocol: ceil(30 ÷ 20) = 2. Usable peptide remaining in an opened vial carries forward to the next dose.
- Full protocol (12 weeks)
- 2 vials (30 mg needed ÷ 20 mg)
Insulin syringes (U-100, 1 mL)
One fresh syringe per administration.
- Full protocol (12 weeks)
- 60 syringes
Bacteriostatic water (10 mL bottles)
Use 3 mL per vial for reconstitution (2 × 3 mL = 6 mL).
- Full protocol (12 weeks)
- 1 × 10 mL bottle
Alcohol swabs
One for the vial stopper per draw + one for each injection site (5 days on / 2 days off). Recommend 2 × 100-count boxes.
- Full protocol (12 weeks)
- 120 swabs
| Supply | Full protocol (12 weeks) |
|---|---|
| Livagen vials (20 mg each)Vials are rounded up only after calculating the whole protocol: ceil(30 ÷ 20) = 2. Usable peptide remaining in an opened vial carries forward to the next dose. | 2 vials (30 mg needed ÷ 20 mg) |
| Insulin syringes (U-100, 1 mL)One fresh syringe per administration. | 60 syringes |
| Bacteriostatic water (10 mL bottles)Use 3 mL per vial for reconstitution (2 × 3 mL = 6 mL). | 1 × 10 mL bottle |
| Alcohol swabsOne for the vial stopper per draw + one for each injection site (5 days on / 2 days off). Recommend 2 × 100-count boxes. | 120 swabs |
Livagen dosage FAQs
How much bacteriostatic water do you use to reconstitute Livagen?
Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration. for a 20 mg Vial vial. Add the water slowly against the inside wall of the vial and swirl — never shake — until the powder fully dissolves.
How often is Livagen administered in research protocols?
Injection frequency: Once daily — 5 days on, 2 days off (dose Mon–Fri, rest Sat–Sun).
What does the Livagen dosing schedule look like?
Weeks 1–2 — 0.5 mg (500 mcg) — 7.5 units (0.075 mL); Weeks 3–4 — 1.0 mg (1000 mcg) — 15 units (0.15 mL); Weeks 5–6 — 1.5 mg (1500 mcg) — 22.5 units (0.225 mL); Weeks 7–12 — 2.0 mg (2000 mcg) — 30 units (0.30 mL). The full table above lists every step with matching syringe units.
What are the mixing steps for Livagen?
Draw 3.0 mL bacteriostatic water with a sterile syringe. Inject slowly down the vial wall; avoid foaming. Gently swirl/roll until dissolved (do not shake).
How should reconstituted Livagen be stored?
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles..
How many insulin syringe units equal a Livagen dose?
Units depend on the water volume you used. Divide your target dose by the vial concentration to get millilitres, then multiply by 100 — 1 unit on a U-100 insulin syringe is 0.01 mL. The Spartan Peptides reconstitution calculator does this conversion for you.
Is Livagen approved for human use?
No. Livagen is sold and referenced strictly as a research chemical. Nothing on this page is medical advice and the material is not for human consumption.
Educational and research information only. Not medical advice, not for human consumption. Values are reference figures — always verify your own math with the reconstitution calculator.
On any insulin syringe, 1 unit = 0.01 mL, so unit counts above hold across brands.